LINCOLN
Invest Now

Lincoln Pharmaceuticals Share Price
₹553.35 +0.25 (0.05%)
21 Mar, 2025 13:32
Start SIP in
LINCOLN
Performance
- Low
- ₹551
- High
- ₹564
- 52 Week Low
- ₹499
- 52 Week High
- ₹980
- Open Price₹553
- Previous Close₹553
- Volume35,751
Investment Returns
- Over 1 Month -1.97%
- Over 3 Month -31.86%
- Over 6 Month -24.08%
- Over 1 Year -8.29%
Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!
Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 12.4
- PEG Ratio
- 5.2
- Market Cap Cr
- 1,108
- P/B Ratio
- 1.7
- Average True Range
- 28.49
- EPS
- 44.62
- Dividend Yield
- 0.3
- MACD Signal
- -37.79
- RSI
- 42.28
- MFI
- 37.86
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹553.35
+
0.25
(0.05%)

-
- Bearish Moving Average 10
-
- Bullish Moving Average 6
- 20 Day
- ₹562.48
- 50 Day
- ₹625.67
- 100 Day
- ₹666.14
- 200 Day
- ₹668.35
Resistance and Support
552.7
- R3 575.40
- R2 567.70
- R1 560.40
- S1 545.40
- S2 537.70
- S3 530.40
Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-13 | Quarterly Results | |
2024-11-14 | Quarterly Results | |
2024-08-08 | Quarterly Results | |
2024-05-16 | Audited Results & Final Dividend | |
2024-02-08 | Quarterly Results |
Lincoln Pharmaceuticals F&O
About Lincoln Pharmaceuticals
- NSE Symbol
- LINCOLN
- BSE Symbol
- 531633
- Managing Director
- Mr. Mahendra G Patel
- ISIN
- INE405C01035
Similar Stocks to Lincoln Pharmaceuticals
Lincoln Pharmaceuticals FAQs
Lincoln Pharmaceuticals share price is ₹553 As on 21 March, 2025 | 13:18
The Market Cap of Lincoln Pharmaceuticals is ₹1108.3 Cr As on 21 March, 2025 | 13:18
The P/E ratio of Lincoln Pharmaceuticals is 12.4 As on 21 March, 2025 | 13:18
The PB ratio of Lincoln Pharmaceuticals is 1.7 As on 21 March, 2025 | 13:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.